Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia

Leukemia Research

Volumn 34, Issue 8, 2010, Pages

  Kashimura, Makoto ^a   Ohyashiki, Kazuma ^b  

^a Matsudo City Hospital   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BCR ABL PROTEIN; CD33 ANTIGEN; CD34 ANTIGEN; CYTARABINE; HLA DR ANTIGEN; IDARUBICIN; IMATINIB; MICROSOMAL AMINOPEPTIDASE; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID;

AGED; CANCER CHEMOTHERAPY; CASE REPORT; CELL CYCLE; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; DEBRIDEMENT; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FUSION GENE; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; LETTER; LEUKEMIA CELL; LEUKOCYTOSIS; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; MYELOBLAST; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; BLAST CRISIS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; OXIDES; PIPERAZINES; PROGNOSIS; PYRIMIDINES; TRANSLOCATION, GENETIC;

EID: 77953620758     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.030     Document Type: Letter

References (5)

1. Baccarani M., Cortes J., Pane F., Niederwieser D., Saglio G., Apperley J., et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European leukemia. Net J Clin Oncol 2009, 27:6041-6051.
2. Graham S.M., Jørgensen H.G., Allan E., Pearson C., Alcorn M.J., Richmond L., et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002, 99:319-325.
3. Ito K., Bernardi R., Morotti A., Matsuoka S., Saglio G., Ikeda Y., et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008, 453:1072-1079.
4. Lallemand-Breitenbach V., Jeanne M., Benhenda S., Nasr R., Lei M., Peres L., et al. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 2008, 10:547-555.
5. Zhang Q.Y., Mao J.H., Liu P., Huang Q.H., Lu J., Xie Y.Y., et al. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL associated leukemia. Proc Natl Acad Sci USA 2009, 106:3378-3383.